DAFINTOR Trademark

Trademark Overview

On Thursday, March 23, 2006, a trademark application was filed for DAFINTOR with the United States Patent and Trademark Office. The USPTO has given the DAFINTOR trademark a serial number of 79023631. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, March 23, 2016. This trademark is owned by NOVARTIS AG. The DAFINTOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, haematology, ophthalmology, in transplantation; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines; pharmaceutical preparations for diagnostic purposes, namely, diagnostic preparations for medical purposes
dafintor

General Information

Serial Number79023631
Word MarkDAFINTOR
Filing DateThursday, March 23, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, March 23, 2016
Registration Number3294207
Registration DateTuesday, September 18, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 3, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, haematology, ophthalmology, in transplantation; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines; pharmaceutical preparations for diagnostic purposes, namely, diagnostic preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 25, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, October 21, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, October 21, 2016DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 20, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, April 23, 2015GENERIC MADRID TRANSACTION SENT TO IB
Thursday, April 23, 2015GENERIC MADRID TRANSACTION CREATED
Thursday, December 25, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 25, 2014CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, June 21, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 26, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 8, 2008FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 8, 2008FINAL DISPOSITION PROCESSED
Tuesday, December 18, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 18, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, July 3, 2007PUBLISHED FOR OPPOSITION
Wednesday, June 13, 2007NOTICE OF PUBLICATION
Wednesday, April 25, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 21, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 6, 2007EXAMINER'S AMENDMENT ENTERED
Friday, April 6, 2007EXAMINERS AMENDMENT E-MAILED
Friday, April 6, 2007EXAMINERS AMENDMENT -WRITTEN
Thursday, April 5, 2007NON-FINAL ACTION E-MAILED
Thursday, April 5, 2007NON-FINAL ACTION WRITTEN
Thursday, April 5, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, March 17, 2007WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, February 20, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 20, 2007ASSIGNED TO LIE
Friday, January 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 12, 2007EXAMINER'S AMENDMENT ENTERED
Friday, January 12, 2007EXAMINERS AMENDMENT E-MAILED
Friday, January 12, 2007EXAMINERS AMENDMENT -WRITTEN
Monday, January 8, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, December 8, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, November 11, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 9, 2006ASSIGNED TO LIE
Monday, November 6, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 31, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, October 31, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, October 31, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, October 2, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 2, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 29, 2006REFUSAL PROCESSED BY IB
Monday, September 11, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 11, 2006REFUSAL PROCESSED BY MPU
Friday, September 8, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 7, 2006NON-FINAL ACTION WRITTEN
Thursday, September 7, 2006ASSIGNED TO EXAMINER
Friday, June 16, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, June 15, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

dafintor system preparations disorders pharmaceutical anti purposes diagnostic prevention treatment infectives